Atlas Trials

Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%

Clinical trial NCT02913521 · COMPLETED

Trial details

NCT number
NCT02913521
Sponsor
Akorn, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoarthritis, Knee
Start date
2015-06-01
Primary completion
2016-04-01
Enrollment
934

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.